NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Contact the NSABP
Pathology Section
Future Meetings
NSABP Newsletters
Media Info on cMYC Study
Media Info on STAR
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-36
Protocol B-37
Protocol B-39
Protocol B-40
Protocol B-41
Protocol B-42
Protocol C-10
Protocol R-04
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
BreastCancerPrevention.com
Bibliography of Publications
Related Web Sites
About the NSABP Web Site
Helper Applications
Links to Major Search Engines
Medical Search Engines
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
P-2
Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial.
Stephanie R. Land; D. Lawrence Wickerham; Joseph P. Costantino; Marcie W. Ritter; Victor G. Vogel; Myoungkeun Lee; Eduardo R. Pajon; James L. Wade III; Shaker Dakhil; James B. Lockhart Jr; Norman Wolmark; Patricia A. Ganz
JAMA. 2006;295:2742-2751. Published online June 5, 2006.
P-2
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial.
Victor G. Vogel; Joseph P. Costantino; D. Lawrence Wickerham; Walter M. Cronin; Reena S. Cecchini; James N. Atkins; Therese B. Bevers; Louis Fehrenbacher; Eduardo R. Pajon Jr; James L. Wade III; André Robidoux; Richard G. Margolese; Joan James; Scott M. Lippman; Carolyn D. Runowicz; Patricia A. Ganz; Steven E. Reis; Worta McCaskill-Stevens; Leslie G. Ford; V. Craig Jordan; Norman Wolmark; for the National Surgical Adjuvant Breast and Bowel Project (NSABP)
JAMA. 2006;295:2727-2741. Published online June 5, 2006.
C-06
Oral Uracil and Tegafur Plus Leucovorin Compared with Intravenous Fluorouracil and Leucovorin in Stage II and III Carcinoma of the Colon: Results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC, Wieand HS, Petrelli NJ, O’Connell MJ, Colangelo LH, Smith RE, Seay TE, Giguere JK, Marshall ME, Jacobs AD, Colman LK, Soran A, Yothers G, Wolmark N
J Clin Oncol. 2006;24(13):2059-64.
B-27
Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Bear HD, Anderson S, Smith RE, Geyer CE Jr, Mamounas EP, Fisher B, Brown AM, Robidoux A, Margolese R, Kahlenberg MS, Paik S, Soran A, Wickerham DL, Wolmark N
J Clin Oncol. 2006;24(13):2019-27. Epub 2006 Apr 10.
B-31
Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-positive Breast Cancer.
Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N
N Engl J Med. 2005;353(16):1673-84.
P-1
Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Fisher B, Costantino J, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah M, Atkins J, Margolese R, Runowicz CD, James J, Ford L, Wolmark N
J Natl Cancer Inst. 2005;97(22):1652-62.
B-31
Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab as Adjuvant Therapy in Node-positive, Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: NSABP B-31.
Tan-Chiu E, Yothers G, Romond E, Geyer CE Jr, Ewer M, Keefe D, Shannon RP, Swain SM, Brown A, Fehrenbacher L, Vogel V, Seay TE, Rastogi P, Mamounas EP, Wolmark N, Bryant J
J Clin Oncol. 2005; 23(31):7811-9.
B-28
Paclitaxel After Doxorubicin Plus Cyclophosphamide as Adjuvant Chemotherapy for Node-positive Breast Cancer: Results from NSABP B-28.
Mamounas EP, Bryant J, Lembersky B, Fehrenbacher L, Sedlacek SM, Fisher B, Wickerham DL, Yothers G, Soran A, Wolmark N
J Clin Oncol. 2005; 23(16):3689-96. Epub 2005 May 16.
B-27
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Mamounas EP, Brown A, Anderson S, Smith RE, Julian TB, Miller B, Bear HD, Caldwell C, Walker A, Mikkelson W, Stauffer J, Robidoux A, Theoret H, Soran A, Fisher B, Wickerham DL, Wolmark N
J Clin Oncol. 2005;23(12):2694-702. Erratum in: J Clin Oncol. 2005 Jul 20;23(21):4808.
FC-AL-001
Pemetrexed/Oxaliplatin for First-line Treatment of Patients with Advanced Colorectal Cancer: A Phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.
Atkins JN, Jacobs SA, Wieand HS, Smith RE, John WJ, Colangelo LH, Vogel VG, Kuebler JP, Cescon TP, Miller BJ, Geyer CE Jr, Wolmark N
Clin Colorectal Cancer. 2005;5(3):181-7.
B-13, B-19, B-23
Effects of Obesity and Race on Prognosis in Lymph Node-negative, Estrogen Receptor-negative Breast Cancer.
Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL.
Breast Cancer Res Treat. Epub 2005 Dec 6.
B-32
Pre-Randomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial: A Randomized Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer.
Harlow S, Krag D, Julian T, Ashikaga T, Weaver D, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL Jr, Noyes RD, Beitsch P
Ann Surg. 2005;241(1):48-54.
P-1
Benign Gynecologic Conditions Among Participants in the Breast Cancer Prevention Trial.
Chalas E, Costantino J, Wickerham DL, Wolmark N, Lewis GC, Bergman C, Runowicz CD
Am J Obstet Gynecol. 2005;192(4):1230-7; discussion 1237-9.
B-14, B-20
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer.
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N
N Engl J Med. 2004 Dec 10; [Epub ahead of print]
B-13, B-14, B-15, B-16, B-17, B-18, B-19, B-20, B-21, B-22, B-23, B-24, B-25
Contralateral Breast Cancer and Thromboembolic Events in African American Women Treated with Tamoxifen.
McCaskill-Stevens W, Wilson J, Bryant J, Mamounas E, Garvey L, James J, Cronin W, Wickerham DL
J Natl Cancer Inst. 2004 Dec 1;96(23):1762-9.
B-15, B-16, B-18, B-22, B-25
Patterns of Locoregional Failure in Patients with Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results from Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials.
Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N
J Clin Oncol. 2004 Nov 1;22(21):4247-54. Epub 2004 Sep 27.
B-14, B-20
Treatment of Lymph-Node-Negative, Oestrogen-Receptor-Positive Breast Cancer: Long-Term Findings from National Surgical Adjuvant Breast and Bowel Project Randomised Clinical Trials.
Fisher B, Jeong JH, Bryant J, Anderson S, Dignam J, Fisher ER, Wolmark N; National Surgical Adjuvant Breast and Bowel Project Randomised Clinical Trials
Lancet. 2004 Sep 4;364(9437):858-68.
C-01
Randomized Trial of Adjuvant Therapy in Colon Carcinoma: 10-Year Results of NSABP Protocol C-01.
Smith RE, Colangelo L, Wieand HS, Begovic M, Wolmark N
J Natl Cancer Inst. 2004 Aug 4;96(15):1128-32.
B-23
Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings From the National Surgical Adjuvant Breast and Bowel Project B-23.
Land SR, Kopec JA, Yothers G, Anderson S, Day R, Tang G, Ganz PA, Fisher B, Wolmark N
Breast Cancer Res Treat. 2004 Jul;86(2):153-64.
R-01, R-02
Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer: A Pooled Analysis.
Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM
J Clin Oncol. 2004 May 15;22(10):1785-96. Epub 2004 Apr 05.
P-1
Lower-Category Benign Breast Disease and the Risk of Invasive Breast Cancer.
Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N
J Natl Cancer Inst. 2004 Apr 21;96(8):616-20.
B-32
NSABP-32: Phase III, Randomized Trial Comparing Axillary Resection with Sentinal Lymph Node Dissection: A Description of the Trial
Krag DN, Julian TB, Harlow SP, Weaver DL, Ashikaga T, Bryant J, Single RM, Wolmark N
Annals of Surgical Oncology 2004 March;11(3 Suppl):208S-210S
B-17
Pathologic Findings from the National Surgical Adjuvant Breast and Bowel Project: Twelve-Year Observations Concerning Lobular Carcinoma in Situ.
Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N
Cancer. 2004 Jan 15;100(2):238-44.
B-27
The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Bear HD, Anderson S, Brown A, Smith R, Mamounas EP, Fisher B, Margolese R, Theoret H, Soran A, Wickerham DL, Wolmark N; National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Journal of Clinical Oncology 2003 November 15;21(22):4165-4174 Epub 2003 October 14
B-09, B-14, B-21, B-23, B-24, P-1
A Review of Selective Estrogen Receptor Modulators and National Surgical Adjuvant Breast and Bowel Project Clinical Trials
Smith RE
Seminars in Oncology 30(5 Suppl 16):4-13, October 2003
B-15, B-16, B-18, B-22, B-23, B-25
Risk for the Development of Treatment-Related Acute Myelocytic Leukemia and Myelodysplastic Syndrome Among Patients with Breast Cancer: Review of the Literature and the National Surgical Adjuvant Breast and Bowel Project Experience
Smith RE
Clinical Breast Cancer 4(4);273-279, October 2003
B-04, B-06
The Incidence of Lung Carcinoma After Surgery for Breast Carcinoma With and Without Postoperative Radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) Clinical Trials B-04 and B-06
Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B
Cancer 98(7):1362-1368, October 1, 2003
B-14
Obesity, Tamoxifen Use, and Outcomes in Women with Estrogen Receptor-Positive Early-Stage Breast Cancer
Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP
Journal of the National Cancer Institute 95(19):1467-1476, October 1, 2003
B-06, B-09, B-13, B-14, B-16, B-17, B-20, B-21, -B-23, B-24, P-1, P-2
Chemoprevention of Breast Cancer and the Trials of the National Surgical Adjuvant Breast and Bowel Project and Others
Smith RE, Good BC
Endocrine-Related Cancer 10(3)347-357, September 2003
R-01, C-01
Lack of Influence of Cytokeratin-Positive Mini Micrometastases in "Negative Node" Patients with Colorectal Cancer: Findings from the National Surgical Adjuvant Breast and Bowel Projects Protocols R-01 and C-01
Fisher ER, Colangelo L, Wieand HS, Fisher B, Wolmark N
Diseases of the Colon and Rectum 46(8):1021-1025; discussion 1025-1026, August 2003
B-18
International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations
Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, Howell A, Costa SD, Beuzeboc P, Untch M, Blohmer JU, Sinn HP, Sittek R, Souchon R, Tulusan AH, Volm T, Senn HJ
Journal of Clinical Oncology 21(13):2600-2608, July 1, 2003
B-15, B-16, B-18, B-22, B-23, B-25
Acute Myeloid Leukemia and Myelodysplastic Syndrome After Doxorubicin-Cyclophosphamide Adjuvant Therapy for Operable Breast Cancer: The National Surgical Adjuvant Breast and Bowel Project Experience
Smith RE, Bryant J, DeCillis A, Anderson S; National Surgical Adjuvant Breast and Bowel Project Experience
Journal of Clinical Oncology 21(7):1195-1204, April 1, 2003
P-1
Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer
Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B, Wolmark N
Journal of the National Cancer Institute 95(4):302-307, February 19, 2003
R-01
Prognosis After Rectal Cancer in Blacks and Whites Participating in Adjuvant Therapy Randomized Trials
Dignam JJ, Ye Y, Colangelo L, Smith R, Mamounas EP, Wieand HS, Wolmark N
Journal of Clinical Oncology 21(3):413-420, February 1, 2003
B-32
Technical Limitations of Sentinel Node Biopsy in Breast Cancer: A Single Surgeon's Experience
Patel NA, Dusi D, Bragdon G, Julian TB
The American Surgeon 69(2)111-116, February 2003
C-01, C-02, C-03, C-04
Prognostic Value of Thymidylate Synthase, Ki-67, and p53 in Patients With Dukes' B and C Colon Cancer: a NCI-NSABP Collaborative Study
Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Wieand HS
Journal of Clinical Oncology 21(2):241-250, January 15, 2003
B-24, P-1
National Surgical Adjuvant Breast and Bowel Project Update: Prevention Trials and Endocrine Therapy of Ductal Carcinoma in Situ
Vogel VG, Costantino JP, Wickerham DL, Cronin WM
Clinical Cancer Research 9(1 Pt 2):495S-501S, January 2003
P-1
Effect of Tamoxifen on Venous Thrombosis Risk Factors in Women Without Cancer: the Breast Cancer Prevention Trial
Cushman M, Costantino JP, Bovill EG, Wickerham DL, Buckley L, Roberts JD, Krag DN
British Journal of Hematology 120(1):109-116, January 2003
B-35
NSABP B-35: A Clinical Trial to Compare Anastrozole and Tamoxifen for Postmenopausal Patients with Ductal Carcinoma In Situ Undergoing Lumpectomy with Radiation Therapy
Julian TB, Land SR, Wolmark N
Breast Diseases: A Year Book Quarterly 14(2):121-122, 2003
R-01, R-02, R-03
Novel Approaches to the Treatment of Locally Advanced Rectal Cancer
Smith RE
Advances in Colon Cancer 7:11-14, 2003
P-1. P-2
Tamoxifen Versus Raloxifene in the Prevention of Breast Cancer
Wickerham DL
European Journal of Cancer 38 (Suppl 6): S20-S21, 2002
BP-58
Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58
Smith RE, Anderson SJ, Brown A, Scholnik AP, Desai AM, Kardinal CG, Lembersky BC, Mamounas EP
Clinical Breast Cancer 3(5):333-340, 2002
B-30, BP-58
Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58
Smith RE, Anderson SJ, Brown A, Scholnik AP, Desai AM, Kardinal CG, Lembersky BC, Mamounas EP
Clinical Breast Cancer 3(5):333-340, December, 2002
B-23QOL
The Impact of Hormonal Treatments on Quality of Life of Patients With Metastatic Breast Cancer
Costantino J
Clinical Therapeutics 24(Suppl C):C26-42, 2002
B-31
Moving Forward: Herceptin in the Adjuvant Setting
Tan-Chiu E, Piccart M
Oncology 63 Suppl 1:57-63, 2002
C-04
Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukess B and C Carcinoma of the Colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04
Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham DL, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher ER, Fisher B
Classic Papers and Current Comments 6(4):936-942, 2002
C-01, C-02, C-03, C-04
Comparative Efficacy of Adjuvant Chemotherapy in Patients With Dukes' B Versus Dukes' C Colon Cancer: Results From Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies
Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J, Rockette H
Classic Papers and Current Comments 6(4):920-927, 2002
B-06
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation For the Treatment of Invasive Breast Cancer
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N
New England Journal of Medicine 347(16):1233-1241, October 17, 2002
B-06, B-21
Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less
Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S, Pisansky TM, Wolmark N
Journal of Clinical Oncology 20(20):4141-4149, October 15, 2002
P-1, B-14, B-16, B-17, B-20, B-23, B-24
Tamoxifen - An Update on Current Data and Where It Can Now Be Used
Wickerham DL
Breast Cancer Research and Treatment 75 Suppl 1:S7-12; Discussion S33-5, October, 2002
B-04
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N
New England Journal of Medicine 347(8):567-575, August 22, 2002
B-18
Pathobiology of Preoperative Chemotherapy: Findings From the National Surgical Adjuvant Breast and Bowel (NSABP) Protocol B-18
Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N
Cancer 95(4):681-695, August 15, 2002
P-1, P-2
The Study of Tamoxifen and Raloxifene: Preliminary Enrollment Data From a Randomized Breast Cancer Risk Reduction Trial
Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Wolmark N
Clinical Breast Cancer 3(2):153-159, June, 2002
B-31
Real-World Performance of HER2 Testing - National Surgical Adjuvant Breast and Bowel Project Experience
Paik S, Bryant J, Tan-Chiu E, Romond E, Hiller W, Park K, Brown A, Yothers G, Anderson S, Smith R, Wickerham DL, Wolmark N
Journal of the National Cancer Institute 94(11):852-854, June 5, 2002
B-18
Effect of Preoperative Chemotherapy on Local-Regional Disease in Women With Operable Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-18
Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV
Classic Papers and Current Comments 5(4):682-693, 2001
B-22
Increased Intensification and Total Dose of Cyclophosphamide in a Doxorubicin-Cyclophosphamide Regimen for the Treatment of Primary Breast Cancer: Finding from National Surgical Adjuvant Breast and Bowel Project B-22
Fisher B, Anderson S, Wickerham DL, DeCillis A, Dimitrov N, Mamounas E, Wolmark N, Pugh R, Atkins JN, Meyers FJ, Abramson N, Wolter J, Bornstein RS, Levy L, Romond EH, Caggiano V, Grimaldi M, Jochimsen P, Deckers P
Classic Papers and Current Comments 5(4):669-681, 2001
B-16
Postoperative Chemotherapy and Tamoxifen Compared With Tamoxifen Alone in the Treatment of Positive-Node Breast Cancer Patients Aged 50 Years and Older With Tumors Responsive to Tamoxifen: Results from NSABP B-16
Fisher B, Redmond C, Legault-Poisson S, Dimitrov NV, Brown AM, Wickerham DL, Wolmark N, Margolese RG, Bowman D, Glass AG, Kardinal CG, Robidoux A, Jochimsen P, Cronin W, Deutsch M, Fisher ER, Myers DB, Hoehn JL
Classic Papers and Current Comments 5(4):630-643, 2001
B-15
Two Months of Ddoxorubicin-Cyclophosphamide With and Without Interval Reinduction Therapy Compared With 6 Months of Cyclophosphamide, Methotrexate, and Florouracil in Positive-Node Breast Cancer Patients With Tamoxifen-Monresponsive Tumors: Results the National Surgical Adjuvant Breast and Bowel Project B-15
Fisher B, Brown AM, Dimitrov NV, Poisson R, Redmond C, Margolese RG, Bowman D, Wolmark N, Wickerham L, Kardinal CG, Shibata H, Paterson AH, Sutherland CM, Robert NJ, Ager PJ, Levy L, Wolter J, Wozniak T, Fisher ER, Deutsch M
Classic Papers and Current Comments 5(4):644-657, 2001
P-1, P-2
Benefit/Risk Assessment of SERM Therapy: Clinical Trial Versus Clinical Practice Settings
Costantino JP
Annals of the New York Academy of Sciences 949:280-285 December, 2001
P-1, P-2
The Role of Tamoxifen in Breast Cancer Prevention: Issues Sparked by the NSABP Breast Cancer Prevention Trial (P-1)
Wolmark N, Dunn BK
Annals of the New York Academy of Sciences 949:99-108 December, 2001
P-1
Quality of Life and Tamoxifen in a Breast Cancer Prevention Trial: A Summary of Findings From the NSABP P-1 Study
Day R.
Annals of the New York Academy of Sciences 949:143-50 December, 2001
P-1, P-1G
Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B; National Surgical Adjuvant Breast and Bowel Project
JAMA : the Journal of the American Medical Association 286(18):2251-2256 November 14, 2001
P-1
Tamoxifen and Depression: More Evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study
Day R, Ganz PA, Costantino JP
Journal of the National Cancer Institute 93(21):1615-1623, November 7, 2001
B-27
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Breast Cancer
Julian TB, Patel N, Dusi D, Olson P, Nathan G, Jasnosz K, Isaacs G, Wolmark N
American Journal of Surgery 182(4):407-410 October 2001
B-14, B-17, B-24, P-1
Ductal Carcinoma in Situ
Wickerham DL
Journal of Clinical Oncology 19(18 Suppl):98S-100S, September 15, 2001
B-17, B-24, P-1
Prevention of Invasive Breast Cancer in Women with Ductal Carcinoma in Situ: an Update of the National Surgical Adjuvant Breast and Bowel Project Experience
Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N
Seminars in Oncology 28(4):400-418, August 2001
B-18
Preoperative (Neoadjuvant) Chemotherapy in Patients with Breast Cancer
Mamounas EP, Fisher B
Seminars in Oncology 28(4):389-399, August 2001
B-18, B-27
Incorporating Genomics into the Cancer Clinical Trial Process
Paik S
Seminars in Oncology 28(3):305-309, June 2001
P-1, P-2
Breast Cancer Chemoprevention: Current Status and Future Directions
Wickerham DL, Tan-Chiu E
Seminars in Oncology 28(3):253-259, June 2001
B-18
Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-year Results From National Surgical Adjuvant Breast and Bowel Project B-18
Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B
Journal of the National Cancer Institute Monogr (30):96-102, 2001
B-13, B-14, B-19, B-20, B-21, B-23
Findings From Recent National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies in Stage I Breast Cancer
Fisher B, Jeong JH, Dignam J, Anderson S, Mamounas E, Wickerham DL, Wolmark N
Journal of the National Cancer Institute Monogr (30):62-66, 2001
B-14
Duration of Adjuvant Tamoxifen Therapy
Bryant J, Fisher B, Dignam J
Journal of the National Cancer Institute Monogr (30):56-61, 2001
B-06, B-09, B-11, B-15, B-18, B-22, B-25
Adjuvant Therapy For Very Young Women With Breast Cancer: Need For Tailored Treatments
Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J, Gelber S, Castiglione-Gertsch M, Coates AS
Journal of the National Cancer Institute Monogr (30):44-51, 2001
B-13, B-14, B-15, B-16, B-19, B-20, B-22
Efficacy of Systemic Adjuvant Therapy for Breast Cancer in African-American and Caucasian Women
Dignam JJ
Journal of the National Cancer Institute Monogr (30):36-43, 2001
B-14
Five Versus More Than Five Years of Tamoxifen for Lymph Node-Negative Breast Cancer: Updated Findings From The National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial
Fisher B, Dignam J, Bryant J, Wolmark N
Journal of the National Cancer Institute 93(9):684-90, May 2, 2001
B-06
Fifteen-Year Prognostic Discriminants for Invasive Breast Carcinoma
Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N
Cancer 91(S8):1679-87, April 15, 2001
P-1
Tamoxifen and Cardiac Risk Factors in Healthy Women: Suggestion of an Anti-Inflammatory Effect
Cushman M, Costantino JP, Tracy RP, Song K, Buckley L, Roberts JD, Krag DN
Arteriosclerosis, Thrombosis, and Vascular Biology 21(2):255-61, February, 2001
B-23
Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23
Fisher B, Anderson S, Tan-Chiu E, Wolmark N, Wickerham DL, Fisher ER, Dimitrov NV, Atkins JN, Abramson N, Merajver S, Romond EH, Kardinal CG, Shibata HR, Margolese RG, Farrar WB
Journal of Clinical Oncology 19(4):931-42, February 15, 2001
C-01, C-02, C-03, C-04, C-05, C-06
National Surgical Adjuvant Breast and Bowel Project Trials in Colon Cancer
Wolmark N, Colangelo L, Wieand S
Seminars in Oncology 28(1 Suppl 1):9-13, February 2001
B-06, B-13, B-14, B-19, B-20
Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes
Fisher B, Dignam J, Tan-Chiu E, Anderson S, Fisher ER, Wittliff JL, Wolmark N
Journal of the National Cancer Institute 93(2):112-20, January 17, 2001
P-1
Cardiovascular Effects of Tamoxifen in Women With and Without Heart Disease: Breast Cancer Prevention Trial
Reis SE, Costantino JP, Wickerham DL, Tan-Chiu E, Wang J, Kavanah M
Journal of the National Cancer Institute 93(1):16-21, January 3, 2001
B-15
HER2 and Choice of Adjuvant Chemotherapy for Invasive Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15
Paik S, Bryant J, Tan-Chiu E, Yothers G, Park C, Wickerham DL, Wolmark N
Journal of the National Cancer Institute 92(24):1991-8, December 20, 2000
C-06
UFT/Leucovorin vs 5-FU/Leucovorin in Colon Cancer
Smith RE, Lembersky BC, Wieand HS, Colangelo L, Mamounas EP
Oncology 14(10 Suppl 9):24-7, October 2000
R-02
Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
Wolmark N, Wieand HS, Hyams DM, Colangelo L, Dimitrov NV, Romond EH, Wexler M, Prager D, Cruz AB Jr, Gordon PH, Petrelli NJ, Deutsch M, Mamounas E, Wickerham DL, Fisher ER, Rockette H, Fisher B
Journal of the National Cancer Institute 92(5):388-96, March 1, 2000
Differences in Breast Cancer Prognosis Among African-American and Caucasian Women
Dignam JJ
CA - A Cancer Journal for Clinicians 50(1):50-64, January-February 2000
B-26
Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients with Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26
Smith RE, Brown AM, Mamounas EP, Anderson SJ, Lembersky BC, Atkins JH, Shibata HR, Baez L, DeFusco PA, Davila E, Tipping SJ, Bearden JD, Thirlwell MP
Journal of Clinical Oncology 17(11):3403-3411, November 1999
B-25
Further Evaluation of Intensified and Increased Total Dose of Cyclophosphamide for the Treatment of Primary Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-25
Fisher B, Anderson S, DeCillis A, Dimitrov N, Atkins JN, Fehrenbacher L, Henry PH, Romond EH, Lanier KS, Davila E, Kardinal CG, Laufman L, Pierce HI, Abramson N, Keller AM, Hamm JT, Wickerham DL, Begovic M, Tan-Chiu E, Tian W, Wolmark N
Journal of Clinical Oncology 17(11):3374-3388, November 1999
C-01, C-02, C-03, C-04, C-05
Outcomes Among African-Americans and Caucasians in Colon Cancer Adjuvant Therapy Trials: Findings From the National Surgical Adjuvant Breast and Bowel Project
Dignam JJ, Colangelo L, Tian W, Jones J, Smith R, Wickerham DL, Wolmark N
Journal of the National Cancer Institute 91(22):1933-40, November 17, 1999
C-04
Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04
Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham DL, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher ER, Fisher B
Journal of Clinical Oncology 17(11):3553-3559, November 1999
P-1
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V
Journal of the National Cancer Institute 91(21):1829-46, November 3, 1999
P-1
Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence
Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS
Journal of the National Cancer Institute 91(18):1541-8, September 15, 1999
P-1
Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Day R, Ganz P, Costantino J, Cronin W, Wickerham DL, Fisher B
Journal of Clinical Oncology 17(9):2659-2669, September 1999
B-17
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma
Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N
Cancer 86(3):429-38, August 1, 1999
B-24
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH
Lancet 353(9169):1993-2000, June 12, 1999
B-13, B-14, B17, B-18, B-19, B-20, P-1
Highlights from Recent National Surgical Adjuvant Breast and Bowel Project Studies in the Treatment and Prevention of Breast Cancer
Fisher B
CA - A Cancer Journal for Clinicians 49(3):159-177, May-June 1999
C-01, C-02, C-03, C-04
Comparative Efficacy of Adjuvant Chemotherapy in Patients with Dukes' B Versus Dukes' C Colon Cancer: Results From Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04)
Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J, Rockette H
Journal of Clinical Oncology 17(5):1349-1355, May 1999
B-18, B-27
Overview of National Surgical Adjuvant Breast Project Neoadjuvant Chemotherapy Studies
Mamounas EP
Seminars in Oncology 6 (Suppl 3):31-35, 1998
B-14
S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer
Bryant J, Fisher B, Gunduz N, Costantino JP, Emir B
Breast Cancer Research and Treatment 51(3):239-53, 1998
B-14
Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project
Dignam JJ; Bryant J; Wieand HS; Fisher B; Wolmark N
Control Clin Trials 19(6):575-88, December 1998
C-05
Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa- 2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05
Wolmark N; Bryant J; Smith R; Grem J; Allegra C; Hyams D; Atkins J; Dimitrov N; Oishi R; Prager D; Fehrenbacher L; Romond E; Colangelo L; Fisher B
Journal of the National Cancer Institute 90:23:1810-6, 1998
P-1
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N
Journal of the National Cancer Institute 90:18:1371-1388, 1998
B-11
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, Fisher ER, Lippman ME, Wickerham DL, Wolmark N
Journal of the National Cancer Institute 90:18:1361-1370, 1998
B-18
Effect of Preoperative Chemotherapy on the Outcome of Women with Operable Breast Cancer
Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB Jr, Hoehn JL, Lees AW, Dimitrov NV, Bear HD
Journal of Clinical Oncology 16(8):2672-2685, 1998
B-14
Long-Term Tamoxifen Citrate Use and Potential Ocular Toxicity
Gorin MB, Day R, Costantino JP, Fisher B, Redmond CK, Wickerham L, Gomolin JE, Margolese RG, Mathen MK, Bowman DM, Kaufman DI, Dimitrov NV, Singerman LJ, Bornstein R, Wolmark N
American Journal of Ophthalmololy 125(4):493-501, April 1998
P-1
Compliance with Quality of Life Data Collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial
Ganz PA, Day R, Costantino J
Statistics in Medicine 17(5-7):613-622, March-April 1998
B-17
Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17
Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, and Kavanah M
Journal of Clinical Oncology 16(2):441-452, 1998
C-06
Future Directions in the Adjuvant Treatment of Colon Cancer
Mamounas EP, Wieand HS, Jones J, Wickerham DL, Wolmark N
Oncology 11:9 (Suppl. No 10):44-47, September 1997
B-27
NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel
Mamounas EP
Oncology 11:6 (Suppl. No 6):37-40, June 1997
B-06
Lumpectomy Margins and Much More
Fisher ER
Cancer 79.8:1453-1458, 1997
B-20
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Fisher B, Dignam J, Wolmark N, DeCillis A, Emir B, Wickerham DL, Bryant J, Dimitrov N, Abramson N, Atkins J, Shibata H, Deschenes L, Margolese R
Journal of the National Cancer Institute 89.22:1673-1682, 1997
R-03
A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Adjuvant Breast and Bowel Project R-03
Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand HS, Deutsch M, Wickerham DL, Fisher B, Wolmark N
Diseases of the Colon & Rectum 40(2):131-139, February 1997
B-18
Effect of Preoperative Chemotherapy on Local-Regional Disease in Women with Operable Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV
Journal of Clinical Oncology 15:2483-2493, 1997
B-14
Coronary Heart Disease Mortality and Adjuvant Tamoxifen Therapy
Costantino J, Kuller L, Ives D, Fisher B, Dignam J.
Journal of the National Cancer Institute 89:11, 1997
B-22
Increased Intensification and Total Dose of Cyclophosphamide in a Doxorubicin-Cyclophosphamide Regimen for the Treatment of Primary Breast Cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-22
Fisher B, Anderson S, Wickerham DL, DeCillis A, Dimitrov N, Mamounas E, Wolmark N, Pugh R, Atkins JN, Meyers FJ, Abramson N, Wolter J, Bornstein RS, Levy L, Romond EH, Caggiano V, Grimaldi M, Jochimsen P, and Deckers P.
Journal of Clinical Oncology 15:5:1858-1869, 1997
B-13, B-14
Prognosis among African-American Women and White Women with Lymph Node Negative Breast Carcinoma
Dignam J, Redmond C, Fisher B, Costantino J, Edwards B.
Cancer 80:80-90, 1997
B-17
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ
Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N
Cancer 78(7):1403-16, October 1996
B-06
A Comment on the Rates of Ipsilateral Breast Tumor Recurrence (IBTR) on NSABP Protocol B-06
Anderson S, Fisher B, Wieand HS
World Journal of Surgery 20(4):514-515, May 1996
B-14
Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors
Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N, Costantino J, Redmond C, Fisher E, Bowman D, Couture J, Dimitrov N, Margolese R, Robidoux A, Shibata H, Terz J, Paterson A, Feldman M, Farrar W, Evans J, Lickely H.
Journal of the National Cancer Institute 88:1529-42, 1996
B-13, B-19
Sequential Methotrexate 5-Fluorouracil (M->F) for the Treatment of Node-Negative Breast Cancer Patients with Estrogen-Receptor-Negative Tumors: Eight-Year Results from NSABP B-13 and First Report of Findings from NSABP B-19 Comparing M->F with Conventional CMF
Fisher B, Dignam J, Mamounas EP, Costantino J, Wickerham DL, Redmond C, Wolmark N, Dimitrov N, Bowman D, Glass A, Atkins J, Abramson N, Sutherland C, Aron B, Margolese R, and other contributing NSABP investigators
Journal of Clinical Oncology 14:7:1982-1992, 1996
B-17
Pathologic Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-17: Intraductal Carcinoma (Duct Carcinoma In Situ)
Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas EP, and NSABP collaborating investigators
Cancer 75:1310-1319, 1995
B-06
Reanalysis and Results After 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer
Fisher B, Anderson S, Redmond C, Wolmark N, Wickerham DL, and Cronin W
New England Journal of Medicine 333:22:1456-1461, 1995
P-1
Baseline Quality of Life Assessment in the NSABP Breast Cancer Prevention Trial
Ganz PA, Day R, Ware JE, Redmond C, and Fisher B
Journal of the National Cancer Institute 87:18:1372-1382, 1995
BP-53, BP-54
The Efficacy of RHu-CSF and RHu GM-CSF in Permitting the Administration of Higher Doses of Cyclophosphamide in a Doxorubicin-Cyclophosphamide Combination: An NSABP Pilot Study in Patients with Metastatic or High-Risk Primary Breast Cancer
Mamounas EP, Anderson S, Wickerham DL, Clark R, Stoller R, Hamm JT, Stewart JA, Bear HB, Glass AG, Bornstein R, and Fisher B
American Journal of Clinical Oncology 17:374-381, 1994
B-14
Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings from NSABP B-14
Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, and Cronin W
Journal of the National Cancer Institute 86:527-537, 1994
B-06, B-17
Conservative Surgery for the Management of Invasive and Noninvasive Carcinoma of the Breast: The NSABP Trials
Fisher B and Anderson S
World Journal of Surgery 18:63-69, 1994
R-01
The Role of Thymidylate Synthase Expression in Prognosis and Outcome to Adjuvant Chemotherapy in Patients with Rectal Cancer
Johnston PG, Fisher ER, Rockett HE, Fisher B, Wolmark N, Chabner BA, and Allegra CJ
Journal of Clinical Oncology 12:2640-2647, 1994
C-03
The Benefit of Leucovorin-Modulated Fluorouracil as Postoperative Adjuvant Therapy for Primary Colon Cancer: Results From NSABP Protocol C-03
Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ, Spurr CL, Dimitrov N, Romond EH, Sutherland CM, Kardinal CG, DeFusco PA, Jochimsen P, and other NSABP investigators
Journal of Clinical Oncology 11:1879-1887, 1993
B-06
Pathologic Findings From the National Surgical Adjuvant Breast and Bowel Project Protocol B-06: Ten-Year Pathologic and Clinical Prognostic Discriminants
Fisher ER, Anderson S, Redmond C, Fisher B, and NSABP collaborating investigators
Cancer 71:2507-2514, 1993
B-17
Lumpectomy Compared With Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer
Fisher B, Costantino J, Redmond C, Fisher ER, Margolese R, Dimitrov N, Wickerham DL, Wolmark N, Deutsch M, Ore L, Mamounas EP, Kavanah M
New England Journal of Medicine 328:1581-1586, 1993
B-13, B-14
Systemic Therapy in Node-Negative Patients: Updated Findings From NSABP Clinical Trials
Fisher B and Redmond C
JNCI Monographs 11:105-116, 1992
B-06
Significance of Ipsilateral Breast Tumor Recurrence After Lumpectomy
Fisher B, Anderson S, Fisher ER, Redmond C, Mamounas EP, Wickerham DL, Wolmark N, and Margolese RG
The Lancet 338:327-331, August 3, 1991
B-14
Effect of Tamoxifen on Serum Insulinlike Growth Factor - I Levels in Stage I Breast Cancer Patients
Pollak M, Costantino J, Constantin P, Blauer S-A, Guyda H, Redmond C, Fisher B, and Margolese R
Journal of the National Cancer Institute 82:1693-1697, 1990
B-10
Evaluation of the Worth of Corynebacterium Parvum in Conjuction with Chemotherapy as Adjuvant Treatment for Primary Breast Cancer: Eight-Year Results from NSABP B-10
Fisher B, Brown A, Wolmark N, Fisher ER, Redmond C, Wickerham DL, Margolese R, Dimitrov N, Pilch Y, Glass A, Sutherland C, and Foster R
Cancer 66:220-227, 1990
C-02
Adjuvant Therapy of Dukes' A, B, and C Adenocarcinoma of the Colon with Portal-Vein Fluorouracil Hepatic Infusion: Preliminary Results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02
Wolmark N, Rockette H, Wickerham DL, Fisher B, Redmond C, Fisher ER, Potvin M, Davies RJ, Jones J, Robidoux A, Wexler M, Gordon P, Cruz AB, Horsley S, Nims TA, Thirlwell M, Phillips WA, Prager D, Stern HS, Lerner HJ, and Frazier TG
Journal of Clinical Oncology 8:1466-1475, 1990
B-15
Two Months of Doxorubicin-Cyclophosphamide With and Without Interval Reinduction Therapy Compared with Six Months of Cyclophosphamide, Methotrexate, and Fluorouracil in Positive-Node Breast Cancer Patients with Tamoxifen-Nonresponsive Tumors: Results from NSABP B-15
Fisher B, Brown AM, Dimotrov NV, Poisson R, Redmond C, Margolese RG, Bowman D, Wolmark N, Wickerham DL, Kardinal CG, Shibata H, Paterson AHG, Sutherland CM, Robert NJ, Ager PJ, Levy L, Wolter J, Wozniak T, Fisher ER, and Deutsch M
Journal of Clinical Oncology 8:1483-1496, 1990
B-16
Postoperative Chemotherapy and Tamoxifen Compared with Tamoxifen Alone in the Treatment of Positive-Node Breast Cancer Patients Aged 50 years and Older with Tumors Responsive to Tamoxifen: Results from NSABP B-16
Fisher B, Redmond C, Legault-Poisson S, Dimitrov NV, Brown AM, Wickerham DL, Wolmark N, Margolese RG, Bowman D, Glass AG, Kardinal CG, Robidoux A, Jochimsen P, Cronin W, Deutsch M, Fisher ER, Myers DB, and Hoehn JL
Journal of Clinical Oncology 8:1005-1018, 1990
B-13, B-14
Systemic Therapy in Patients with Node-Negative Breast Cancer: A Commentary Based on Two National Surgical Adjuvant Breast and Bowel Project (NSABP) Clinical Trials
Fisher B, Redmond C, Wickerham DL, Wolmark N, Bowman D, Couture J, Dimitrov NV, Margolese R, Legault-Poisson S, and Robidoux A
Annals of Internal Medicine 111:703-712, 1989
B-06
Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy With or Without Irradiation in the Treatment of Breast Cancer
Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham DL, Fisher E, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, and Sidorovich L
New England Journal of Medicine 320:822-828, 1989
B-14
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer who have Estrogen-Receptor-Positive Tumors
Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickley HL, and Ketner M
New England Journal of Medicine 320:479-484, 1989
C-01
Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-01
Wolmark N, Fisher B, Rockette H, Redmond C, Wickerham DL, Fisher ER, Jones J, Glass A, Lerner H, Lawrence W, Prager D, Wexler M, Evans J, Cruz A, Dimitrov N, and Jochimsen P
Journal of the National Cancer Institute 80:30-36, 1988
R-01
Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results from NSABP Protocol R-01
Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, Fisher ER, Caplan R, Jones J, Lerner H, Gordon P, Feldman M, Cruz A, Legault-Poisson S, Wexler M, Lawrence W, and Robidoux A
Journal of the National Cancer Institute 80:21-29, 1988
B-11, B-12
Increased Benefit From Addition of Adriamycin to Adjuvant Therapy for Stage II Breast Cancer: Results From NSABP Protocols B-11 and B-12
Fisher B, Wickerham DL, Redmond C, Wolmark N, Glass A, Bowman D, Jochimsen P, and Poisson S
Proceedings American Society of Clinical Oncology 6:62, 1987
B-09
Prolonging Tamoxifen Therapy for Primary Breast Cancer: Findings From the National Surgical Adjuvant Breast and Bowel Project Clinical Trial
Fisher B, Brown A, Wolmark N, Redmond C, Wickerham DL, Wittliff J, Dimitrov N, Poisson SL, Schipper H, and Prager D
Annals of Internal Medicine 106:649-654, 1987
B-06
The Technique of Segmental Mastectomy (Lumpectomy) and Axillary Dissection: A Syllabus From the National Surgical Adjuvant Breast and Bowel Project Workshops
Margolese R, Poisson R, Shibata H, Pilch Y, Lerner H, and Fisher B
Surgery 102:828-834, 1987
B-05
Ten-Year Results from the NSABP Clinical Trial Evaluating the Use of L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer
Fisher B, Fisher ER, and Redmond C
Journal of Clinical Oncology 4:929-941, 1986
B-09
Adjuvant Chemotherapy With and Without Tamoxifen in the Treatment of Primary Breast Cancer: 5-Year Results from the NSABP Trial
Fisher B, Redmond C, Brown A, Fisher ER, Wolmark N, Bowman D, Plotkin D, Wolter J, Bornstein R, Legault-Poisson S, and Saffer EA
Journal of Clinical Oncology 4:459-471, 1986
B-04
Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy With or Without Resection
Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, and Foster R
New England Journal of Medicine 312:674-681, 1985
B-06
Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy With or Without Radiation in the Treatment of Breast Cancer
Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher E, Wolmark N, Deutsch M, Montague E, Saffer E, Wickerham DL, Lerner H, Glass A, Shibata H, Deckers P, Ketcham A, Oishi R, and Russell I
New England Journal of Medicine 312:665-673, 1985
B-09
Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen
Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Geggie P, Campbell T, Elias EG, Prager D, Koontz P, Volk H, Dimitrov N, Gardner B, Lerner H, and Shibata H
New England Journal of Medicine 305:1-6, 1981
B-05, B-07
L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer: An Update of Earlier Findings and a Comparison with Those Utilizing L-PAM Plus 5-Fluorouracil (5-FU)
Fisher B, Glass A, Redmond C, Fisher ER, Barton B, Such E, Carbone P, Economou S, Foster R, Frelick R, Lerner H, Levitt M, Margolese R, MacFarlane J, Plotkin D, Shibata H, and Volk H<br> Cancer 39:2883-2903, 1977
B-04
Comparison of Radical Mastectomy with Alternative Treatments for Primary Breast Cancer: A First Report of Results from a Prospective Randomized Clinical Trial
Fisher B, Montague E, Redmond C, Barton B, Borland D, Fisher ER, Deutsch M, Schwarz G, Margolese R, Donegan W, Volk H, Konvolinka C, Gardner B, Cohn I, Lesnick G, Cruz AB, Lawrence W, Nealon T, Butcher H, and Lawton R
Cancer 39:2827-2839, 1977
B-04
The Pathology of Invasive Breast Cancer: A Syllabus Derived from Findings of the National Surgical Adjuvant Breast and Bowel Project (Protocol No. 4)
Fisher ER, Gregorio RM, Fisher B with the assistance of Redmond C, Vellios F, and Sommers SC
Cancer 36:1-85, 1975